Pulmonary Divisions, University Hospital of Zurich, Zurich, Switzerland.
Respiration. 2010;79(3):200-8. doi: 10.1159/000222094. Epub 2009 May 27.
Utility indices are used in cost-effectiveness analyses as a measure of quality of life reflecting the patient's preference for a given health state on a scale anchored at 0 (corresponding to death) to 1 (perfect health). It is uncertain which utility instruments are most suitable for application in patients with the obstructive sleep apnea syndrome (OSA).
To compare utility indices obtained in OSA patients by various instruments.
In 66 untreated OSA patients (median Epworth score 12, apnea/hypopnea index, AHI, 57/h), five different utility instruments were employed. In 34 OSA patients, changes in utility after 4 months of continuous positive airway pressure (CPAP) were retrieved from published SF-36 data.
In 66 OSA patients, median (quartiles) utility indices were: standard gamble 0.97 (0.89; 0.99); time trade-off 0.94 (0.81; 0.99); EuroQol questionnaire (EQ-5D) 0.92 (0.83; 1.00); Euro-thermometer visual analog scale 0.80 (0.70; 0.90); SF-36 questionnaire (SF-6D) 0.75 (0.69; 0.85; p < 0.05 SF-6D and Euro-thermometer utility vs. other indices). Different utility indices were poorly correlated among each other and with AHI and Epworth scores. SF-6D utility after 4 months of CPAP had changed by 0.04 (0.02; 0.12, p = 0.026).
Utility indices measured by different instruments vary largely and some indices reflect the impaired quality of life in OSA poorly. Interpretation of cost-effectiveness analyses should account for the utility instrument used.
效用指数被用于成本效益分析中,作为衡量生活质量的指标,反映患者对给定健康状态的偏好程度,其范围在 0(对应死亡)到 1(完全健康)之间。目前尚不确定哪些效用工具最适合用于阻塞性睡眠呼吸暂停综合征(OSA)患者。
比较不同工具在 OSA 患者中测量的效用指数。
在 66 例未经治疗的 OSA 患者(中位 Epworth 评分为 12,呼吸暂停/低通气指数,AHI,57/h)中,使用了五种不同的效用工具。在 34 例 OSA 患者中,从已发表的 SF-36 数据中检索到 4 个月持续气道正压通气(CPAP)治疗后效用的变化。
在 66 例 OSA 患者中,中位(四分位数)效用指数分别为:标准博弈法 0.97(0.89;0.99);时间权衡法 0.94(0.81;0.99);欧洲五维健康量表(EQ-5D) 0.92(0.83;1.00);欧洲温度计视觉模拟量表 0.80(0.70;0.90);SF-36 问卷(SF-6D)0.75(0.69;0.85;p<0.05 SF-6D 和 Euro-thermometer 效用与其他指数相比)。不同的效用指数之间相关性较差,与 AHI 和 Epworth 评分也相关性较差。CPAP 治疗 4 个月后 SF-6D 的效用变化了 0.04(0.02;0.12,p=0.026)。
不同工具测量的效用指数差异很大,有些指数反映 OSA 患者的生活质量较差。成本效益分析的解释应考虑使用的效用工具。